Canada markets closed

Chong Kun Dang Pharmaceutical Corp. (185750.KS)

KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
94,600.00-7,000.00 (-6.89%)
At close: 03:30PM KST
Currency in KRW

Valuation Measures4

Market Cap (intraday) 1.21T
Enterprise Value 1.03T
Trailing P/E 5.90
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.71
Price/Book (mrq)1.46
Enterprise Value/Revenue 0.62
Enterprise Value/EBITDA 3.55

Trading Information

Stock Price History

Beta (5Y Monthly) 0.90
52-Week Change 320.25%
S&P500 52-Week Change 326.24%
52 Week High 3136,500.00
52 Week Low 30.00
50-Day Moving Average 3102,660.00
200-Day Moving Average 3106,662.81

Share Statistics

Avg Vol (3 month) 336.71k
Avg Vol (10 day) 356.24k
Shares Outstanding 512.74M
Implied Shares Outstanding 612.87M
Float 87.59M
% Held by Insiders 143.71%
% Held by Institutions 116.97%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 41100
Forward Annual Dividend Yield 41.16%
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 40.94
Payout Ratio 46.86%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 27, 2023
Last Split Factor 21.05:1
Last Split Date 3Dec 27, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 12.14%
Operating Margin (ttm)8.53%

Management Effectiveness

Return on Assets (ttm)11.90%
Return on Equity (ttm)27.83%

Income Statement

Revenue (ttm)1.67T
Revenue Per Share (ttm)131,046.88
Quarterly Revenue Growth (yoy)-1.00%
Gross Profit (ttm)N/A
EBITDA 283.21B
Net Income Avi to Common (ttm)202.24B
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)-28.70%

Balance Sheet

Total Cash (mrq)393.3B
Total Cash Per Share (mrq)30,992.93
Total Debt (mrq)216.98B
Total Debt/Equity (mrq)26.25%
Current Ratio (mrq)1.90
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)321.13B
Levered Free Cash Flow (ttm)172.72B